American Century Companies’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,796
Closed -$502K 2942
2025
Q1
$502K Buy
79,796
+1,653
+2% +$10.4K ﹤0.01% 2508
2024
Q4
$322K Buy
78,143
+24,153
+45% +$99.5K ﹤0.01% 2662
2024
Q3
$180K Sell
53,990
-118
-0.2% -$394 ﹤0.01% 2776
2024
Q2
$161K Buy
54,108
+7,902
+17% +$23.5K ﹤0.01% 2769
2024
Q1
$159K Buy
46,206
+25,143
+119% +$86.7K ﹤0.01% 2801
2023
Q4
$28.2K Sell
21,063
-364
-2% -$488 ﹤0.01% 2866
2023
Q3
$46.7K Buy
+21,427
New +$46.7K ﹤0.01% 2811